The present invention provides a mutant virus, preferably an influenza virus, from a human or another animal, and a preparation method for the mutant virus. The method comprises of introducing a UAG codon upstream of an endogenous stop codon of one or more genes in a viral genome. The invention further provides applications of the mutant virus as an attenuated live vaccine or as a replicable and controllable safe virus model.